[HTML][HTML] Nimotuzumab: beyond the EGFR signaling cascade inhibition
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …
activates multiple signaling cascades that promote carcinogenesis and immune evasion …
Nimotuzumab: beyond the EGFR signaling cascade inhibition
Z Mazorra, L Chao, A Lavastida… - Seminars in …, 2018 - pubmed.ncbi.nlm.nih.gov
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …
activates multiple signaling cascades that promote carcinogenesis and immune evasion …
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Z Mazorra, L Chao, A Lavastida, B Sanchez… - Seminars in …, 2018 - europepmc.org
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …
activates multiple signaling cascades that promote carcinogenesis and immune evasion …